Kanagawa, Japan

Haruhi Kamisaki




Average Co-Inventor Count = 7.9

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2013-2015

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Haruhi Kamisaki: Innovator in Medicinal Chemistry

Introduction

Haruhi Kamisaki is a prominent inventor based in Kanagawa, Japan. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating serious mental health conditions. With a total of three patents to her name, her work is recognized for its potential impact on pharmaceutical advancements.

Latest Patents

Haruhi Kamisaki's latest patents include innovative compounds that target phosphodiesterase 10A (PDE10A) inhibitors. One of her notable inventions is a heterocyclic compound that provides a medicament for preventing or treating schizophrenia. This compound is represented by a specific formula, which includes various salts and prodrugs. Another significant patent involves a condensed heterocyclic compound that exhibits superior PDE10A inhibitory action, further showcasing her expertise in this area.

Career Highlights

Throughout her career, Haruhi has been associated with Takeda Pharmaceutical Company Limited, where she has played a crucial role in research and development. Her work has not only contributed to the company's portfolio but has also advanced the understanding of medicinal compounds in treating complex disorders.

Collaborations

Haruhi has collaborated with esteemed colleagues such as Masato Yoshikawa and Tomoaki Hasui. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.

Conclusion

Haruhi Kamisaki stands out as a leading inventor in the field of medicinal chemistry, with her patents reflecting her commitment to improving mental health treatments. Her contributions continue to influence the pharmaceutical industry and inspire future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…